We will exhibit our cutting-edge non-invasive glucose monitor, GlucoBeam at ATTD 2019
ATTD, one of the world’s leading scientific forums for showcasing the latest breakthroughs in diabetes technology, will be held in Berlin later this week. Set to make our first conference appearance as an exhibitor at the prestigious New Technologies Fair, we will unveil the version of GlucoBeam to be used in our upcoming pivotal trial, a key step towards obtaining regulatory approval in Europe.
The device represents the culmination of over 10 years of research and testing to integrate the company’s proprietary critical depth Raman technology into an all-in-one consumer glucose monitor for daily home-use. While the hardware is similar to the future commercial version, the software is still being finalised in preparation for GlucoBeam’s market launch.
We are extremely excited about the opportunity to introduce RSP Systems to industry specialists, scientists and key opinion leaders at ATTD and to showcase our trial-ready device. We are looking forward to making the premium consumer version of GlucoBeam available to the public soon.
Anders Weber, CSO will be giving a talk at the fair and we will be present at Booth 42.